Evidence map›Paper›PMID 42037371›Full record

ArticleInternational journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience2026

Testing DAT1 and DRD4 Genes in Attention Deficit Hyperactivity Disorder Using a Wide Spectrum of Neurocognitive Batteries.

Gül Ünsel-Bolat, Hilmi Bolat, Sema Yıldırım, Semiha Özgül, Akın Tahıllıoğlu, Kemal Utku Yazıcı, Ali Bacanlı, Erhan Parıltay, Duygu Aygüneş-Jafari, Buket Kosova and 3 more

Abstract read
In one paragraph

Article in International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Gül Ünsel-BolatDepartment of Child and Adolescent Psychiatry, Balıkesir University, Balıkesir, Turkey.ORCID https://orcid.org/0000-0002-4574-421X
Hilmi BolatDepartment of Medical Genetics, Balıkesir University, Balıkesir, Turkey.ORCID https://orcid.org/0000-0001-6574-8149
Sema YıldırımDepartment of Child and Adolescent Psychiatry, Balıkesir University, Balıkesir, Turkey.
Semiha ÖzgülBiostatistics and Medical Informatics, Ege University, İzmir, Turkey.
Akın TahıllıoğluDepartment of Child and Adolescent Psychiatry, Bakırçay University, İzmir, Turkey.ORCID https://orcid.org/0000-0002-3952-3672
Kemal Utku YazıcıDepartment of Child and Adolescent Psychiatry, Fırat University, Elazığ, Turkey.
Ali BacanlıDepartment of Child and Adolescent Psychiatry, Private Practice, İzmir, Turkey.
Erhan ParıltayDepartment of Medical Genetics, Ege University, İzmir, Turkey.
Duygu Aygüneş-JafariMedical Biology, Ege University, İzmir, Turkey.
Buket KosovaMedical Biology, Ege University, İzmir, Turkey.
Luis Augusto RohdeDepartment of Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Haluk AkınDepartment of Medical Genetics, Ege University, İzmir, Turkey.
Eyüp S ErcanDepartment of Child and Adolescent Psychiatry, Ege University, İzmir, Turkey.

Funding

Ege University Scientific Research Projects Coordinator TTU-2018-20009
6 · The paper itself

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition characterized by marked heterogeneity in cognitive functioning. This study aimed to examine the associations between polymorphisms in the DAT1 and DRD4 genes and neurocognitive performance in children and adolescents with ADHD. A total of 336 participants aged 6-18 years (244 with ADHD and 92 healthy controls) were included. Variable number tandem repeat (VNTR) polymorphisms in the 3' UTR of DAT1 and exon 3 of DRD4 were genotyped. Neurocognitive performance was assessed using standardized scores derived from the CNS Vital Signs battery. Associations between genotypes and cognitive domains were examined using analysis of covariance (ANCOVA), adjusting for age and gender. Homozygosity for the DRD4 4-repeat allele was significantly associated with poorer cognitive flexibility, whereas a trend-level difference was observed for complex attention. In contrast, DAT1 10R/10R homozygosity and DRD4 7-repeat allele carriage were not associated with significant differences in reaction time, complex attention or cognitive flexibility. These findings suggest that DRD4, rather than DAT1, may represent a more salient dopaminergic genetic marker of executive dysfunction in ADHD. The results underscore the domain-specific and modest nature of genetic influences on cognition and highlight the importance of integrating genetic markers with cognitive endophenotypes to better characterize heterogeneity in ADHD.

Indexed as

Attention Deficit Disorder with HyperactivityCognition DisordersDopamine Plasma Membrane Transport ProteinsReceptors, Dopamine D4AdolescentChildFemaleGenetic Predisposition to DiseaseGenotypeHumansMaleMinisatellite RepeatsNeuropsychological TestsPolymorphism, GeneticDopamine Plasma Membrane Transport ProteinsDRD4 protein, humanReceptors, Dopamine D4SLC6A3 protein, humanADHDDAT1dopamineDRD4genotypeneurocognitive functionVNTR

Identifiers

PMID42037371
PMCPMC13112133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.